Novel cancer‐specific epidermal growth factor receptor antibody obtained from the serum of esophageal cancer patients with long‐term survival

Although esophageal cancer has a poor prognosis after recurrence, some patients have shown long‐term survival despite recurrence. We hypothesized that induction of either antitumor Abs or antitumor‐specific CTLs could play a role in long‐term survival (5 years or longer) in patients with recurrence...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer science 2022-06, Vol.113 (6), p.2118-2128
Hauptverfasser:	Takagi‐Maeda, Sayaka, Yajima, Satoshi, Suzuki, Takashi, Usami, Katsuaki, Takahashi, Nobuaki, Niwa, Rinpei, Shimada, Hideaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies antibody Antigens cancer specificity Cancer therapies Cloning Cytotoxicity EGFR Epidermal growth factor Epidermal growth factor receptors Esophageal cancer esophageal squamous cell carcinoma Esophagus Kinases Medical prognosis Metastases mRNA Original ORIGINAL ARTICLES Panning Patients Peptides Peripheral blood mononuclear cells phage display Phages Prognosis Proteins Squamous cell carcinoma Tumor suppression Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!